ArticleFrontiers in molecular biosciences2026
Disease classification via interpretable machine learning based on multi-center routine coagulation test.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to establish an interpretable disease classification model via machine learning and identify key features related to the disease to assist clinical disease diagnosis based on a multi-center CX9000 routine coagulation test. Methods: Data from 11 hospitals were collected. An unsupervised clustering model was used to extract classification patterns, and clinical experts assigned disease labels. Multiple machine learning models, including Random Forest, SVM, Decision Tree, Naive Bayes, MLP, XGBoost, and LightGBM, were trained. Ten-fold cross validation and external validation were performed. For external validation, models were trained with data from 8 hospitals (˜90%) and tested on the remaining 2 hospitals (˜10%). SHAP and Decision Tree analysis were used for interpretability. Results: Clear clustering patterns were observed for valvular heart disease (VHD) and pulmonary infection (PI). LightGBM achieved the best performance in both tasks. In cross validation, the mean F1-scores were 0.8890 and 0.7233, and the mean AUCs were 0.9500 and 0.8023. External validation showed strong generalization, with mean F1-scores of 0.9259 and 0.7464 and mean AUCs of 0.9493 and 0.8297. The sample visualization by t-SNE and the interpretable analysis by SHAP and Decision Trees identified some key classification features, i.e., international normalized ratio (INR) for VHD and age for PI. Conclusion: Machine learning models based on multi-center coagulation tests provide effective and interpretable disease classification, supporting clinical diagnostic automation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.